Clinical Trials Logo

Cavernous Angioma clinical trials

View clinical trials related to Cavernous Angioma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03652181 Completed - Clinical trials for Cerebral Cavernous Malformation

CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness

Start date: August 20, 2018
Phase:
Study type: Observational

Brain Cavernous Angiomas with Symptomatic Hemorrhage (CASH) are rare, but they exact a heavy burden of neurologic disability from recurrent bleeding, for which there is no proven therapy. This trial readiness project aims to address current critical obstacles in identifying cases at multiple sites, characterizing their relevant features, and measuring their outcome. The timing cannot be more opportune, with therapeutic targets already identified, exceptional collaboration among researchers and with the patient community, and several drugs ready to benefit from a track to clinical testing in the next five years.